The National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH) in Bethesda, Maryland is seeking a dynamic, innovative and accomplished biomedical/biotechnology executive with demonstrated scientific and entrepreneurial expertise to provide strategic vision and leadership for the Office of Translational Alliances and Coordination (OTAC). The OTAC is charged with developing, implementing and leading translational research programs that create recognizable commercial value for discoveries and innovations during their gestational stages and facilitating their ultimate translation into new diagnostics, devices, therapeutics and tools. The Office is also charged with identifying emerging areas of translational opportunities, serving as a focal point for extramural researchers for information on NHLBI-wide small business technology development opportunities.
The OTAC Director is an expert in entrepreneurism and technology advancement with the vision and unique skill set required to recognize commercial value in very early stage technologies, guide their scientific and business oriented risk-mitigating development and the capital acquisition activities required for their ultimate customer/patient deployment. These skills, gained through experience in both the academic research and the start-up/small business or industry sector, will provide the OTAC Director the capability to oversee and effectively manage existing NHLBI translational research technology development programs and the development of new programs and initiatives required to identify and advance innovations and technology platforms for research, diagnosis, treatment, control and prevention of cardiovascular, lung, blood and sleep disorders.
Major responsibilities include:
- Use knowledge of biomedical technology market needs, regulatory approval pathways, business development, and the current state of the science, to develop and implement programs focused on emerging technologies with potential for high impact in the areas of prevention, detection, diagnosis, or treatment of cardiovascular, lung, blood, and sleep disorders.
- Bring strategic alliances, and develop partnerships that enhance and enable the development, translation and deployment of advanced technology platforms that support the NHLBI mission.
- Survey research and healthcare trends, determine technology development needs and develop initiatives that integrate with the NHLBI programs.
- Organize and lead relevant workshops, conferences, and similar activities to facilitate communication and partnerships between investigators, NIH, private industry, and other technology development stakeholders.
- Serve as a scientific liaison representing the NHLBI vision of strategic technology development to other Institute components, NIH scientists, Federal agencies, the small business and technology development communities, private industry and other stakeholders.
- Oversee the development and implementation of SBIR/STTR programs focused on emerging technologies of national importance in the areas of prevention, detection, diagnosis, or treatment of cardiovascular, lung, blood, and sleep disorders from both the extramural community and the NHLBI intramural program.
- Oversee the development of a grants and contracts portfolio supporting the development of advanced technologies towards commercialization.
- Supervise OTAC staff.
Applicants must possess a PhD or equivalent doctoral degree and biotech/ biomed (e.g. therapeutic, diagnostic, device, tools) research experience. Although not required, an MBA degree or equivalent experience is preferred. Biomed/biotech industry research, development and commercialization experience including knowledge of intellectual property development, regulatory and reimbursement requirements as well as impeccable leadership and communication skills are required. For further information, please contact:
Eric W. Padmore, MHSA
Program Analyst & Project Manager
Office of Translational Alliances & Coordination
National Heart, Lung, & Blood Institute
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.